Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Recruiting · NCT04263038 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism | Embolism, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism | Recruiting | Phase 4 | 2026-05-22 | NCT04263038 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Drahomir Aujesky | 1 |
| Leiden University Medical Center | 183 |
| Schweizerischer Nationalfonds | 1 |
| The Ottawa Hospital | 21 |
| University of Bern | 126 |
40 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.